© 2020 MJH Life Sciences, Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Author | Targeted Oncology
Articles
Targeted Therapy in Early-Stage HER2+ Breast Cancer
July 31, 2020
Video
Experts from Sarah Cannon Research Institute talk about the expanding role of targeted treatment options in early HER2+ breast cancer.
Advancing Survival in Relapsed/Refractory Multiple Myeloma
July 28, 2020
Video
A discussion on a novel therapeutic target for treatment, known as exportin 1 (XPO1), and the first selective nuclear export inhibitor to enter clinical use for patients who have developed relapse after IMiD and protease inhibitor therapies.
Radioiodine Refractory Differentiated Thyroid Carcinoma
July 13, 2020
Video
A key opinion leader discusses the evolving treatment landscape for radioiodine refractory differentiated thyroid carcinoma, with special consideration of the phase 3 SELECT trial.
Role of Targeted Therapies in Advanced Cholangiocarcinoma
July 10, 2020
Video
Saeed Sadeghi, MD, comments on the utilization of FGFR2 inhibitors as treatment for advanced cholangiocarcinoma.